Skip to main content
editorial
. 2006 Jan;96(1):11–13. doi: 10.2105/AJPH.2005.076885

Figure 1.

Figure 1

Without access to generic antiretroviral drugs, treatment for most HIV-positive South Africans would likely be unaffordable. The Siyaphila La [We are living here] HIV-treatment program in the Eastern Cape Province’s Lusikisiki district provides patients with the generic fixed-dose combination drug Triomune. Nozamile Ndarah, age 22, is seen here in 2004 shortly after she has been prescribed the drug. Photo courtesy of Gideon Mendel/Corbis.